atrovent unit dose vials ipratropium bromide 250 micrograms/1 ml (as monohydrate) conventional inhalation ampoule
boehringer ingelheim pty ltd - ipratropium bromide monohydrate, quantity: 261 microgram/ml (equivalent: ipratropium bromide, qty 250 microgram/ml) - inhalation, conventional - excipient ingredients: purified water; sodium chloride; hydrochloric acid - moderate asthmatic attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery, use during assisted ventilation with a respirator. administration of atrovent via a nebuliser is intended for those patients who cannot use a metered dose aerosol.
atrovent adult unit dose vials ipratropium bromide 500 micrograms/1 ml (as monohydrate) conventional inhalation ampoule
boehringer ingelheim pty ltd - ipratropium bromide monohydrate, quantity: 522 microgram/ml (equivalent: ipratropium bromide, qty 500 microgram/ml) - inhalation, conventional - excipient ingredients: sodium chloride; hydrochloric acid; purified water - moderate asthmatic attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery, use during assisted ventilation with a respirator. administration of atrovent via a nebuliser is intended for those patients who cannot use a metered dose aerosol.
atrovent ipratropium bromide 250 micrograms/ml (as monohydrate) conventional inhalation bottle
boehringer ingelheim pty ltd - ipratropium bromide monohydrate, quantity: 0.261 mg/ml (equivalent: ipratropium bromide, qty 0.25 mg/ml) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; sodium chloride; hydrochloric acid; disodium edetate - moderate asthmatic attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery, use during assisted ventilation with a respirator. administration of atrovent via a nebuliser is intended for those patients who cannot use a metered dose aerosol.
atrovent udv sol inh 250mcg/ml solution
boehringer ingelheim (canada) ltd ltee - ipratropium bromide - solution - 250mcg - ipratropium bromide 250mcg - antimuscarinics antispasmodics
atrovent udv 125mcg/ml solution
boehringer ingelheim (canada) ltd ltee - ipratropium bromide - solution - 125mcg - ipratropium bromide 125mcg - antimuscarinics antispasmodics
atrovent solution
boehringer ingelheim (canada) ltd ltee - ipratropium bromide - solution - 250mcg - ipratropium bromide 250mcg - antimuscarinics antispasmodics
atrovent 500 udvs, 500 mcg/2ml nebuliser solution
boehringer ingelheim international gmbh binger strasse 173, 55216 ingelheim am rhein, germany - ipratropium bromide - nebuliser solution - ipratropium bromide 500 µg - drugs for obstructive airway diseases
atrovent 250 udvs 250 micrograms/ 1ml nebuliser solution
boehringer ingelheim limited - ipratropium bromide - nebuliser solution - 250 microgram(s)/millilitre - anticholinergics; ipratropium bromide
atrovent 500 udvs, 500 micrograms/ 2ml nebuliser solution
boehringer ingelheim limited - ipratropium bromide - nebuliser solution - 500 micrograms/2 ml microgram(s) - anticholinergics; ipratropium bromide
atrovent 500 udvs, 500 mcg/2ml nebuliser solution
boehringer ingelheim limited - ipratropium bromide - nebuliser solution - ipratropium bromide 500 µg - drugs for obstructive airway diseases